Il y a eu 50 transactions d'initiés récentes enregistrées pour DBV Technologies S.A. (DBVT), dont 24 achats et 18 ventes. Le total des achats d'initiés s'élève à $9.68M et le total des ventes d'initiés à $5.67M.
Les initiés notables ayant une activité récente comprennent Mohideen Pharis, Baker Bros. Advisors Lp, Epic Bpifrance. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — DBVT
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-01-29 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
534 |
$4.86 |
$2.6K |
144,995 |
| 2026-01-12 |
Baker Bros. Advisors Lp |
Director |
Exercice d'Options (Vente) |
25,005,240 |
- |
- |
- |
| 2025-12-18 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Vente Informative |
1,292,103 |
$4.19 |
$5.41M |
7,303,369 |
| 2025-12-17 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Vente Informative |
40,000 |
$5.28 |
$211.2K |
8,595,472 |
| 2025-11-21 |
Tasse Daniel |
Chief Executive Officer |
Attribution de RSU |
964,000 |
$2.90 |
$2.8M |
964,000 |
| 2025-11-21 |
Boucinha Virginie |
Chief Financial Officer |
Attribution de RSU |
32,000 |
- |
- |
70,000 |
| 2025-11-21 |
Trapp Kevin Michael |
Chief Commercial Officer |
Attribution de RSU |
55,000 |
- |
- |
55,000 |
| 2025-11-21 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
1,624 |
$2.77 |
$4.5K |
101,529 |
| 2025-11-20 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
6,496 |
$2.88 |
$18.71K |
103,153 |
| 2025-11-03 |
Trapp Kevin Michael |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-07-29 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
464 |
$2.22 |
$1.03K |
109,649 |
| 2025-05-22 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
397 |
$1.84 |
$730.48 |
110,113 |
| 2025-04-07 |
Bpifrance Sa |
10 Percent Owner |
Inconnu |
6,556,781 |
- |
- |
- |
| 2025-04-07 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Inconnu |
6,556,781 |
- |
- |
- |
| 2025-03-27 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Attribution de RSU |
2,299,656 |
- |
- |
2,299,656 |
| 2025-03-27 |
Bpifrance Sa |
10 Percent Owner |
Inconnu |
- |
- |
- |
226,133 |
| 2025-03-27 |
Bpifrance Investissement S.a.s. |
Other: Member of 10% Owner Group |
Inconnu |
- |
- |
- |
226,133 |
| 2025-03-27 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Inconnu |
- |
- |
- |
226,133 |
| 2025-01-30 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
600 |
$0.85 |
$510.00 |
110,510 |
| 2024-12-04 |
Tasse Daniel |
Chief Executive Officer |
Attribution de RSU |
813,200 |
$0.89 |
$723.75K |
813,200 |
| 2024-11-25 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
565 |
$0.57 |
$322.05 |
111,110 |
| 2024-11-22 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
342 |
$0.53 |
$181.26 |
111,675 |
| 2024-11-21 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
2,350 |
$0.54 |
$1.27K |
112,017 |
| 2024-11-21 |
Boucinha Virginie |
Chief Financial Officer |
Attribution de RSU |
19,000 |
- |
- |
38,000 |
| 2024-07-29 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
1,785 |
$0.98 |
$1.75K |
79,367 |
| 2024-05-24 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
660 |
$1.36 |
$897.60 |
81,152 |
| 2024-05-22 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
382 |
$1.38 |
$527.16 |
81,812 |
| 2024-03-08 |
Tasse Daniel |
Chief Executive Officer |
Achat Informatif |
17,094 |
$0.83 |
$14.19K |
17,094 |
| 2024-02-06 |
Ndu Adora |
Director |
Achat Informatif |
1,825 |
$0.89 |
$1.62K |
1,825 |
| 2023-11-22 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
2,245 |
$1.74 |
$3.91K |
82,194 |
| 2023-11-20 |
Tasse Daniel |
Chief Executive Officer |
Attribution de RSU |
806,672 |
$2.19 |
$1.77M |
806,672 |
| 2023-11-20 |
Mohideen Pharis |
Chief Medical Officer |
Attribution de RSU |
35,000 |
- |
- |
84,439 |
| 2023-11-20 |
Boucinha Virginie |
Chief Financial Officer |
Attribution de RSU |
19,000 |
- |
- |
19,000 |
| 2023-11-06 |
Boucinha Virginie |
Officer |
Inconnu |
- |
- |
- |
- |
| 2023-08-25 |
Morris Timothy E |
Director |
Achat Informatif |
12,000 |
$1.52 |
$18.24K |
12,000 |
| 2023-08-01 |
Soland Daniel B |
Director |
Achat Informatif |
15,000 |
$1.62 |
$24.3K |
20,000 |
| 2023-05-24 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
469 |
$3.54 |
$1.66K |
49,439 |
| 2022-11-24 |
Mohideen Pharis |
Chief Medical Officer |
Vente Informative |
1,792 |
$2.88 |
$5.16K |
49,908 |
| 2022-11-21 |
Tasse Daniel |
Chief Executive Officer |
Attribution de RSU |
764,386 |
$3.07 |
$2.35M |
764,386 |
| 2022-11-21 |
Mohideen Pharis |
Chief Medical Officer |
Attribution de RSU |
17,500 |
- |
- |
51,700 |
| 2022-11-21 |
Robitaille Sebastien |
Chief Financial Officer |
Attribution de RSU |
8,000 |
- |
- |
36,500 |
| 2022-10-03 |
Guyot-caparros Daniele |
Director |
Inconnu |
- |
- |
- |
- |
| 2022-07-29 |
Mohideen Pharis |
Chief Medical Officer |
Attribution de RSU |
10,000 |
- |
- |
34,200 |
| 2022-06-13 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Attribution de RSU |
1,383,352 |
- |
- |
1,383,352 |
| 2022-06-13 |
Baker Brothers Life Sciences Lp |
Director |
Attribution de RSU |
1,383,352 |
- |
- |
1,383,352 |
| 2021-11-22 |
Tasse Daniel |
Chief Executive Officer |
Attribution de RSU |
274,000 |
$6.62 |
$1.81M |
274,000 |
| 2021-11-22 |
Mohideen Pharis |
Chief Medical Officer |
Attribution de RSU |
8,700 |
- |
- |
24,200 |
| 2021-11-22 |
Robitaille Sebastien |
Chief Financial Officer |
Attribution de RSU |
5,000 |
- |
- |
28,500 |
| 2021-06-10 |
De Rosen Michel |
Director |
Achat Informatif |
6,837 |
$13.09 |
$89.5K |
6,837 |
| 2021-06-10 |
Morris Timothy E |
Director |
Achat Informatif |
6,837 |
$13.09 |
$89.5K |
6,837 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi